Colectomy vs. Colostomy

Colectomy Vs. Colostomy

If you are new to the world of IBD or are having to have a conversation about surgery for IBD it can be confusing when presented with so many similar sounding procedures. The most common confusion in this area is the difference between a colectomy and a colostomy. A colectomy simply means that surgery is … Read more

FDA to Add New Warnings to Popular JAK Inhibitor Xeljanz

Xeljanz

The FDA has just finished its comprehensive review of the popular JAK inhibitor Xeljanz, with some new warnings and safety precautions. The JAK inhibitor has been previously approved for Rheumatoid Arthritis (RA), psoriatic arthritis, ulcerative colitis, and polyarticular course juvenile idiopathic arthritis. This new data collected shows increased risk for adverse cardiovascular events, blood clots, … Read more

5 Types of Remission for IBD

5 types of Remission

For those with Crohn’s and Ulcerative Colitis remission is their long-term goal. Remission can be defined as a period of time where the patient experiences little or no symptoms of their chronic illness. Many IBD patients do not realize there are actually five different types of remission. I have personally had UC now for seven … Read more

New Study Finds Pandemic Brought more Symptoms for those with Gastrointestinal Issues

A new retrospective single-center study found that those suffering from IBS, gastroparesis, and functional dyspepsia experienced more symptoms during the pandemic. This comes as no surprise considering new and added stressors as well as lifestyle changes due to the stay-at-home orders. For these individuals with functional gastrointestinal and motility disorders (FGIMD) this pandemic not only … Read more

The Spoon Theory and Chronic Illness

Spoon theory

Living with a chronic illness can bring lots of different things with it, but more often than not chronic fatigue is one of them. It can make daily activities like showering or driving to work difficult and exhausting. While many people don’t think twice about the energy daily activities take, those of us with chronic … Read more

Does Regular use of Proton Pump Inhibitors Influence IBD Diagnosis?

IBD and PPI Use

A recent pooled analysis from three separate observational studies found that individuals taking proton pump inhibitors (PPIs) had a moderately increased risk of developing IBD. PPIs are commonly referred to as heartburn medication and can be purchased over the counter. Common brands include Prilosec, Prevacid, and Nexium. These medications work by slowing stomach acid production, … Read more

3 Major Benefits of Turmeric for IBD

Turmeric for IBD

Turmeric has been used in India for thousands of years not only as a spice for cooking but as a medicine too. It is only in recent years that science has begun to back up these claims of old. Turmeric is a root plant related to ginger, often turned into a spice. Turmeric contains some … Read more

Probiotics Promising in Reducing Symptoms In Functional GI Disorders

Probiotics for FGID's

A small Belgium pilot study found spore-forming probiotics were safe and effective at treating symptoms in functional dyspepsia. This study was conducted on those with a range of different disorders and diseases under the umbrella of Functional GI Disorders (FGID’s). FGID’s are defined as disorders of the GI function itself and can affect any part … Read more

The Importance of Magnesium in IBD

MG and IBD

Magnesium is vital to your body’s overall health and is responsible for more than 300 chemical reactions. It is essential in the growth, maintenance of bones, nerve function, and muscle movement just to name a few. It also helps neutralize stomach acid and helps move waste through the intestines properly. People with IBD can often … Read more

Remicade Superior in Endoscopic Remission vs. Entyvio for UC

Remicade vs Entyvio

For UC patients naïve to biologics, Remicade (infliximab) was shown to be superior in corticosteroid-free clinical remission, as well as endoscopic remission versus Entyvio (vedolizumab). This recent analysis found that clinical remission percentages were close at year one, with Remicade at 39.9% and Entyvio at 38.6%. Both of these are viable biologic options for the … Read more